| Russell E Brown, MD | |
|
4688 Trinity Ct, Marietta, GA 30068-1671 | |
| (404) 316-4992 | |
| (770) 973-3587 |
| Full Name | Russell E Brown |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 4688 Trinity Ct, Marietta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194769257 | NPI | - | NPPES |
| 00683867B | Medicaid | GA | |
| 13023578 | Other | GA | RR MEDICARE |
| 055003719A | Medicaid | GA | |
| 15-00149 | Other | GA | EVERCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 039743 (Georgia) | Primary |
| Entity Name | Department Of Behavioral Health And Developmental Disabilities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902030307 PECOS PAC ID: 7416002506 Enrollment ID: O20090825000435 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
| Entity Name | Health Education, Assessment And Leadership, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831476399 PECOS PAC ID: 0547429292 Enrollment ID: O20120315000479 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
| Entity Name | A-z Behavioral Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669898961 PECOS PAC ID: 5991931313 Enrollment ID: O20140519000347 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
| Entity Name | Populations And Interventions Team Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730608522 PECOS PAC ID: 7113293960 Enrollment ID: O20180430000730 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
| Entity Name | Uplift Recovery And Wellness Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770367641 PECOS PAC ID: 5991159444 Enrollment ID: O20231002003086 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
| Entity Name | Healthy Minds Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609650258 PECOS PAC ID: 8325483167 Enrollment ID: O20240301003462 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Russell E Brown, MD 4688 Trinity Ct, Marietta, GA 30068-1671 Ph: (404) 316-4992 | Russell E Brown, MD 4688 Trinity Ct, Marietta, GA 30068-1671 Ph: (404) 316-4992 |
News Archive
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
With expiring patents and growing gaps in revenue a reality in today's global pharmaceutical industry, an increasing number of drug manufacturers are beginning to evaluate their supply chains to identify any and all opportunities for savings so that they can continue to bring innovative products to market and remain competitive.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
The European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) today publish their first joint Clinical Practice Guidelines (CPGs) on the management of hepatocellular carcinoma.
Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.
› Verified 3 days ago
Dr. Matthew Charles Agan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 780 Canton Rd Ne Ste 400, Marietta, GA 30060 Phone: 770-488-3602 | |
Robert J Delpozo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2540 Windy Hill Rd Se, Marietta, GA 30067 Phone: 770-644-1570 Fax: 770-644-1576 | |
Karen J Carter, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1650 County Services Pkwy, Marietta, GA 30008 Phone: 770-514-2422 Fax: 770-514-9853 | |
Dr. Kristy Hendricks Jackson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2540 Windy Hill Rd Se, Marietta, GA 30067 Phone: 770-644-1570 | |
Iffat Bhuiyan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2540 Windy Hill Rd Se, Marietta, GA 30067 Phone: 770-644-1570 | |
Dr. David Scott Whitcomb, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1521 Johnson Ferry Rd, Suite 135, Marietta, GA 30062 Phone: 770-579-0777 Fax: 770-579-3777 | |
Dr. Jerry Lee Walters Ii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 718 Cherokee St Ne, Marietta, GA 30060 Phone: 770-291-8987 |